Herd immunity to GII.4 noroviruses is supported by outbreak patient sera - Wikidata - wikimedia - TriplyDB

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

http://www.wikidata.org/entity/Q30375643

about

Norovirus immunity and the great escape Immunogenetic mechanisms driving norovirus GII.4 antigenic variation Experimental inoculation of juvenile rhesus macaques with primate enteric caliciviruses Pathogenesis of noroviruses, emerging RNA viruses Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.Fitting outbreak models to data from many small norovirus outbreaks.The impact of environmental and climatic variation on the spatiotemporal trends of hospitalized pediatric diarrhea in Ho Chi Minh City, Vietnam.Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006 Identification of cross-reactive norovirus CD4+ T cell epitopes Heterotypic humoral and cellular immune responses following Norwalk virus infection.Within-host evolution results in antigenically distinct GII.4 noroviruses Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan.Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.Serological correlate of protection against norovirus-induced gastroenteritis Susceptibility to winter vomiting disease: a sweet matter.Norovirus GII.4 strain antigenic variation Affinities of recombinant norovirus P dimers for human blood group antigens Comparison of age-stratified seroprevalence of antibodies against norovirus GII in India and the United Kingdom Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens.Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains.Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.Norovirus-host interaction: multi-selections by human histo-blood group antigens.Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.Novel GII.12 norovirus strain, United States, 2009-2010.The importance of intergenic recombination in norovirus GII.3 evolution Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.Deep sequencing of norovirus genomes defines evolutionary patterns in an urban tropical setting Seroprevalence in Household Raised Pigs Indicate High Exposure to GII Noroviruses in Rural Nicaragua.Surveillance of norovirus among children with diarrhea in four major hospitals in Bhutan: Replacement of GII.21 by GII.3 as a dominant genotype.Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice.Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population.

P2860

Q21090486-86601DCF-C3A2-4344-9812-D4E04307128C Q24810360-DF8DCF56-8841-4D51-89D4-CF7843E36EB9 Q27302049-C645C711-1525-4A2D-AAD7-C8539A93406B Q28392368-F74C9CAC-DF3F-40AC-A8CE-DCF7BC71532A Q30401642-4746AD26-E1DA-47E3-85F7-A0F91B74326D Q30409563-D5DC6873-2D52-4763-9C9C-ABABFF01E8EB Q30425145-6BBCD01A-5F98-41FC-891D-B050BE7B2A94 Q30769890-5C02003D-8ECC-4942-95F9-F28C9E9E7361 Q30996836-B110A7D0-DC47-4FEC-B88A-027486FA4CF0 Q33614256-C505AE04-D09F-41D4-A240-0E5D8E088692 Q33614545-3016B7BA-A239-41FD-9D4D-C379D8507F6A Q33614589-41A24D25-2B9F-42B2-A94E-A493513CC83C Q33744124-DE108449-AAF8-4FC6-B80F-FEB79D5D4051 Q34046026-67A51010-5ED2-45A9-B30B-E69D08E2D587 Q34059136-C268ABAF-9EAB-479B-BCF6-1D043C57A55D Q34120230-67031DAC-A8A5-4302-9EC9-1A2397DC261D Q34153875-25A11E31-09DE-4AB1-8E26-3957E16C7370 Q34227237-405426B1-C4DD-47EB-8166-C9937A57F909 Q34457831-E9BE8866-DE2B-4D05-BA7C-333CBAC264D7 Q34464196-99198C24-977B-42F1-BF53-3F7296B81EE9 Q34598472-3AB739D4-CF17-40F3-8B52-16942B6ADE2A Q34985473-D26FCFE6-130F-4AAD-B882-B52BCF1D66A8 Q34987998-B4352D00-E9EA-4C8C-8011-811FEE950B7C Q35021149-44940C22-DF79-4F61-8015-1FA9C8B05AD5 Q35076817-6B5C87DB-9860-4210-A5F3-BEE9D541621A Q35146233-7CFCBC91-F544-479F-AB14-529221111643 Q35192903-50E73DCF-C4B9-462E-B4EF-3DB48CE123A0 Q35212408-27282FBE-8B8F-42F7-B9C8-C4FD3240E2A7 Q35665784-048B432D-BDCD-45DA-A34A-021FCB3935F0 Q35983587-3281818D-EAC6-433F-AE52-B83D9D14D5E4 Q36053705-4083237D-BB7E-45FE-8ED6-40FDC5D6DF3F Q36759705-71D11F50-73ED-4EAF-9C05-F45B3C30CA09 Q37547547-C21E6212-33A8-4696-A559-C73BB275EC39 Q38081967-9A7B03EF-1FC3-4074-BAE6-A096EEC320C4 Q38557262-5EAD3281-983D-4D24-84A8-D7C63307FF3D Q38954444-F76EFCAB-D151-4181-B7D7-279A920C01E4 Q39770349-5059D35D-F789-4BDE-875A-C2EEFBC13EA4 Q40046249-FA3796F6-AC84-4C66-9EF7-4AF0032E979A Q40715789-8520DC32-2040-4FA5-996C-15446AF95BFE Q41500656-AF49B234-D6A9-45CE-874A-A348B1D3C1B5

P2860

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

http://www.wikidata.org/entity/Q30375643

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

@ast

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

@en

type

label

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

@ast

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

@en

prefLabel

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

@ast

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

@en

P1433

Q30375643-2ACB7EA8-EE1B-4BC8-AF2B-15C418C178FA

P1476

Q30375643-9E3CFC22-B147-4702-A48A-C5E02F89F817

P2093

Q30375643-001BE899-CEF5-408E-9B76-07D567E32B3A

Q30375643-41755864-53E5-4122-9026-5B3326D4241A

Q30375643-6A6ECAA6-9724-46C7-A698-00B651D6C4B8

Q30375643-C63C9795-BCD4-439D-963E-2066F8B87C9C

P2860

Q30375643-02EA43ED-6858-4757-81C4-09B5D9EDCD79

Q30375643-04383491-9C84-40A6-841E-6E1DB0E63548

Q30375643-04EBEE17-FC1C-4604-9C3C-4EFB49B12D0E

Q30375643-0748F635-EB67-4A8D-A03D-2F5057389C60

Q30375643-09C7A3F0-B6AD-4D44-9FA2-FDF3EBD6D64E

Q30375643-0ED88D23-68BC-4D6B-BB93-97FF5594A89F

Q30375643-133D8E3A-E47A-4BEF-A3BA-A074335B28A9

Q30375643-1550E89E-54A9-44B0-BC21-158C2928B796

Q30375643-2C33972F-653C-4D12-A60B-1F136F684923

Q30375643-2C88AC80-8C05-4BB6-BD6C-B75984690B90

P304

Q30375643-52612386-4B4A-4140-84C0-284B8E66CB5E

P31

Q30375643-045435C5-2910-4A93-8A5C-7483856C2B5C

P356

Q30375643-8A761EBC-E8EB-4D26-887D-1A2D9B79939D

P433

Q30375643-5F50EBB4-EE79-40E7-A3E6-A1A9B64440F9

P478

Q30375643-90B66313-72AB-42DE-85CA-CFDE704D7E21

P50

Q30375643-50FFED1F-F9DA-4D69-B5C6-E4C643D15504

Q30375643-6EED81B3-4445-4559-A0B9-094240230C33

P577

Q30375643-33276491-AE2A-44C9-AC27-760D3A32FDFD

P698

Q30375643-5260D68D-3E4A-4F2D-918F-909024EA130D

P921

Q30375643-5A6DA1FC-5281-4A61-A597-D50129E09AAF

Q30375643-61227E50-87ED-4988-939E-93882AA2DCF2

Q30375643-61AFACAE-2FD3-4FA8-A394-D4189596DCCC

P932

Q30375643-664FB7AC-EEC8-427C-9EFE-783C82CA7A0A

P356

P1433

Journal of Virology

P1476

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

@en

P2093

Eric F Donaldson

http://www.w3.org/2001/XMLSchema#string

Jennifer L Cannon

http://www.w3.org/2001/XMLSchema#string

Lauryn Saxe

http://www.w3.org/2001/XMLSchema#string

Lisa C Lindesmith

http://www.w3.org/2001/XMLSchema#string

P2860

Norwalk virus shedding after experimental human infection

Norovirus and foodborne disease, United States, 1991-2000

A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections

Cellular and humoral immunity following Snow Mountain virus challenge

Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge

Structural basis for the recognition of blood group trisaccharides by norovirus

Comparative protein structure modeling of genes and genomes

Human susceptibility and resistance to Norwalk virus infection

Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004

Mechanisms of GII.4 norovirus persistence in human populations

P304

5363-5374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02518-08

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19297483

http://www.w3.org/2001/XMLSchema#string

P921

P932

2681945

http://www.w3.org/2001/XMLSchema#string